Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Intellia Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 295
- +16 vs. Q3 2024
- Shares held
- 99.3M
- +8.31M (+9.1%) vs. Q3 2024
- Total value
- $1.16B
- −$710.5M (−38.0%) vs. Q3 2024
- New holders
- 65
- 127 more added
- Sold out
- 49
- 68 more reduced
5 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital Advisors Inc | 0 | $0 | 0.00% | −203,775−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −188,316−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −175,023−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −92,000−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −84,121−100.0% | Sold out |
| McGuire Investment Group, LLC | 0 | $0 | 0.00% | −71,301−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −47,899−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −43,962−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −39,262−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −35,994−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −32,279−100.0% | Sold out |
| Woodstock Corp | 0 | $0 | 0.00% | −25,550−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −24,803−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −24,206−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −23,099−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,304−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −19,844−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −18,840−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −18,705−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −16,809−100.0% | Sold out |
| Valence8 US LP | 0 | $0 | 0.00% | −13,020−100.0% | Sold out |
| Relyea Zuckerberg Hanson LLC | 0 | $0 | 0.00% | −11,129−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −9,241−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −7,345−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −6,900−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −2,617−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| Advisors Asset Management, Inc. | 0 | $0 | 0.00% | −1,992−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −233−100.0% | Sold out |
| Gilliland Jeter Wealth Management LLC | 0 | $0 | 0.00% | −212−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −161−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Motco | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Global Wealth Strategies & Associates | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Goodman Advisory Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Contrarius Investment Management Ltd | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |
| Abich Financial Wealth Management LLC | – | – | – | – | Not filed |
| Planning Capital Management Corp | – | – | – | – | Not filed |